Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million Vs. IBES Estimate USD -6.54 Million
TVRD•Quarterly earnings update
Aug. 14 (Reuters) - Tvardi Therapeutics Inc Q2 EPS USD -0.69.
Related News
Digi Power X Q2 FY26 net loss widens to $14.4 million; revenue rises to $6.6 million
DGXX•
Huntington Bank hires Laricke Blanchard as congressional, regulatory relations director
HBAN•
SurgePays Q2 EPS USD 0.05
SURG•
Gri Bio Q2 FY26 net loss narrows to $1.64 million; R&D expenses drop 78.34% to $407,000
GRI•
BlackRock reports Fnac Darty holding rises to 453,879 shares after asset transfer
BLK•